CSI Market
Sign In | Register

Aktis Oncology Inc (AKTS) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access AKTS quarterly Cash Flow →
The cash flow figures below highlight longer-term patterns in how Aktis Oncology Inc manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jun 30 2024)
12 Months 		(Jun 30 2023) (Jun 30 2022) (Jun 30 2021) (Jun 30 2020)
Operating Activities
Income-167.95
Depreciation & amortization22.86
Amortization of Other Assets3.22
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss43.45
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-5.33
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total-0.06
Share-based Compensation2.94
Noncash Contribution Expense0.00
Fair Value Adjustment of Warrants28.92
Change In Unrealized Gain Loss On Fair Value Hedging Instruments-
Change In Fair Value Of Contingent Real Estate Liability-
Increase Decrease In Other Asset-
Increase Decrease In Change In Other Long Term Liabilities-
Stock Issued-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Liabilities Assumed-
Reclassification Of Fixed Assets To Assets Held For Sale Net-
Gain Loss On Derivative Instruments Net Pretax-0.95
Noncash Interest Payments-
Operating Lease Right Of Use Asset Amortization-
Non Cash Interest Payments-
Operating Lease Right Of Use Asset Amortization Expense0.40
Increase Decrease In Operating Lease Liability-0.35
Increase Decreasein Other Long Term Liabilities-
Income taxes39.30
Losses/ -gains on Investments net0.00
Increase (Decrease) in Interest and Dividends Receivable-0.64
Increase (Decrease) in Accounts Payable1.52
Increase (Decrease) in Other Accrued Liabilities0.00
Increase (Decrease) in Customer Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.00
Other Working Capital56.70
Other Noncash Expense2.20
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-40.35
Investing Activities
Capital Expenditures-5.99
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Acquisition Business Net Of Cash Acquired-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-5.99
Financing Activities
Short-term debt Net8.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock19.62
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.07
Proceeds From Employee Stock Purchase Plan-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents80.49
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities27.68
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-46.34
Total Cash Flow-18.66
4 historic quarters locked

Sign in to unlock the full Aktis Oncology Inc cash flow history.

Sign In Create Free Account

About Aktis Oncology Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-349144

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License